Vera A. Zherebtsova
Vera A. Zherebtsova publishes mostly in Hematology, Molecular Biology and Genetics, on topics such as Multiple Myeloma Research and Treatments, Chronic Lymphocytic Leukemia Research and Protein Degradation and Inhibitors.
- World rank
- #2,896,883 of 7,710,434 ranked researchers
- Rank in Russia
- #11,237 of 179,717
- Works
- 55
- Citations
- 396
- Citations per work
- 7.2
What does Vera A. Zherebtsova research?
Vera A. Zherebtsova's work is mostly in Medicine (65%), Biochemistry, Genetics and Molecular Biology (13%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3665.1%
- Medicine3665.1%
- Everything else1222.3%
- Life Sciences712.6%
- 1Hematology30% of their works
- 2Molecular Biology13% of their works
- 3Genetics12% of their works
- 4Oncology9% of their works
- 5Pathology and Forensic Medicine8% of their works
- 6Public Health, Environmental and Occupational Health6% of their works
Research topics
- Multiple Myeloma Research and Treatments
- Chronic Lymphocytic Leukemia Research
- Protein Degradation and Inhibitors
- Lymphoma Diagnosis and Treatment
- Chronic Myeloid Leukemia Treatments
- Viral-associated cancers and disorders
- Acute Lymphoblastic Leukemia research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Which keywords describe Vera A. Zherebtsova's research?
The keywords of their largest research topics: Minimal Residual Disease, Diagnosis Criteria, International Myeloma Working Group, Rituximab, Prognostic Factors, Chronic Lymphocytic Leukemia, Genomic Aberrations and BET Bromodomains.
- JAK2 Mutation
- Epstein-Barr Virus
- Acute Lymphoblastic Leukemia
- BCR-ABL
- Classification
- BET Bromodomains
- Chronic Lymphocytic Leukemia
- Rituximab
- Diagnosis Criteria
- Minimal Residual Disease
- International Myeloma Working Group
- Prognostic Factors
- Genomic Aberrations
- PROTACs
- Lymphoma
- Imatinib
- Childhood Cancer
- Kaposi's Sarcoma
- Myelofibrosis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Minimal Residual Disease382 topics
- Diagnosis Criteria331 topic
- International Myeloma Working Group331 topic
- Rituximab232 topics
- Prognostic Factors182 topics
- Chronic Lymphocytic Leukemia131 topic
- Genomic Aberrations131 topic
- BET Bromodomains111 topic
- PROTACs111 topic
- Classification101 topic
- Lymphoma101 topic
- BCR-ABL61 topic
- Imatinib61 topic
- Acute Lymphoblastic Leukemia51 topic
- Childhood Cancer51 topic
- Epstein-Barr Virus51 topic
- Kaposi's Sarcoma51 topic
- JAK2 Mutation41 topic
- Myelofibrosis41 topic
Where does Vera A. Zherebtsova work?
Vera A. Zherebtsova's main affiliation in the publication record is Botkin Hospital, Russia.
How many publications and citations does Vera A. Zherebtsova have?
OpenAlex counts 55 works and 396 citations for Vera A. Zherebtsova, an h-index of 9, ranking #2,896,883 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Vera A. Zherebtsova. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.